Beta Bionics (BBNX) CPO Mike Mensinger Sells 4,375 Shares

What Happened

• Mike Mensinger, Chief Product Officer of Beta Bionics (BBNX), sold 4,375 shares on 2026-09-02 in an open‑market transaction. The reported proceeds were about $83,620 (reported price $19.11; weighted average $19.1131).

Key Details

• Transaction date: 2026-09-02; Form 4 filed: 2026-09-03 (appears timely).
• Shares sold: 4,375; reported proceeds ≈ $83,620.
• Price details: reported price $19.11; weighted average sale price $19.1131; reported price range $18.89–$19.545. The filing notes full per‑price breakdown is available on request.
• Footnotes: F1 — sale was to cover tax withholding related to the vesting of restricted stock units (RSUs). F2 — weighted average and price range as above.
• Shares owned after transaction: not provided in the data you supplied (check the full Form 4 for post‑transaction holdings).

Context

• This was a sale to satisfy tax withholding on vested RSUs (routine administrative transaction) rather than a new disposition indicating a change in investment view. Sales for tax withholding are common and do not necessarily signal insider sentiment about the company.